Vedolizumab and new‐onset spondyloarthritis: Debunking the myth

Vedolizumab and new‐onset spondyloarthritis: Debunking the myth

Published version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/371167

Files

Bibliographic metadata (6.06 KB)

Primary Published version (147.05 KB)

Type

Authors

Roseira, Joana

https://orcid.org/0000-0002-5098-8729

Marafini, Irene

https://orcid.org/0000-0001-8258-3235

Noor, Nurulamin M.

https://orcid.org/0000-0003-3426-6408

Description

Publication status: Published

Keywords

extra‐intestinal manifestations, adverse effects, treatment, inflammatory bowel disease

Publisher DOI

https://doi.org/10.1002/ueg2.12624

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/

Collections

Jisc Publications Router